NCT02656212View on ClinicalTrials.gov

Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin (Part 2)

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Pre-diabetes
Interventions
DRUG

epicatechin

30 mg (+)-epicatechin, taken orally, one pill/day in the morning

DRUG

Placebo

Placebo pill, taken orally, one pill/day in the morning

Trial Locations (2)

92161

CMR Center for Metabolic Research VASDHS, San Diego

VA San Diego Healthcare System, San Diego

All Listed Sponsors
collaborator

San Diego Veterans Healthcare System

FED

collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

collaborator

University of California, San Diego

OTHER

collaborator

National Institutes of Health (NIH)

NIH

lead

Veterans Medical Research Foundation

OTHER

NCT02656212 - Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin (Part 2) | Biotech Hunter | Biotech Hunter